|
|
|
|
|
| Wang,P.; Luo,J.D.; Wu,W.F.; Wang,S.; Cai,S.L.; Shen,B.H.; Shi,S.F.; Wei,K.X.; Zhang,Z.G.; Chen,Z.D.. |
| Transitional cell carcinoma (TCC) of the urothelium is often multifocal and subsequent tumors may occur anywhere in the urinary tract after the treatment of a primary carcinoma. Patients initially presenting a bladder cancer are at significant risk of developing metachronous tumors in the upper urinary tract (UUT). We evaluated the prognostic factors of primary invasive bladder cancer that may predict a metachronous UUT TCC after radical cystectomy. The records of 476 patients who underwent radical cystectomy for primary invasive bladder TCC from 1989 to 2001 were reviewed retrospectively. The prognostic factors of UUT TCC were determined by multivariate analysis using the COX proportional hazards regression model. Kaplan-Meier analysis was also used to... |
| Tipo: Info:eu-repo/semantics/article |
Palavras-chave: Bladder neoplasm; Transitional cell carcinoma; Upper urinary tract; Radical cystectomy; Prognosis. |
| Ano: 2007 |
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2007000700013 |
| |
|
|
| Zhao,W.P.; Zhang,Z.G.; Li,X.D.; Yu,D.; Rui,X.F.; Li,G.H.; Ding,G.Q.. |
| We investigated the effectiveness of celecoxib in reducing symptoms in patients with difficult chronic pelvic pain syndrome (CPPS), NIH category IIIA. Sixty-four patients with category IIIA CPPS were randomized into two groups of 32 subjects each. One group was treated with celecoxib (200 mg daily) and the other with placebo. All patients underwent treatment for 6 weeks and were evaluated clinically before (baseline) and after 1, 2, 4, 6, and 8 weeks of treatment. The evaluation included the NIH Chronic Prostatitis Symptom Index (NIH-CPSI) and a subjective global assessment (SGA). Repeated measures analysis of variance was used to evaluate treatment and time effects and their interaction. A decrease (means ± SD) in total NIH-CPSI score from 23.91 ± 5.27 to... |
| Tipo: Info:eu-repo/semantics/other |
Palavras-chave: Prostatitis; Chronic pelvic pain syndrome; Cyclooxygenase inhibitors. |
| Ano: 2009 |
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009001000015 |
| |
|
|
|
